Neurolutions IpsiHand Upper Extremity Rehabilitation System Receives FDA De Novo Market Authorization

Neurolutions IpsiHand FDA Authorization
Neurolultions
Neurolutions, Inc., a medtech company with offices in Santa Cruz, California and St. Louis, Missouri, announced that the U.S. FDA granted De Novo market authorization for its groundbreaking IpsiHand Upper […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleNew Hydrogel Material For Wound Treatment Can Kill Antibiotic Resistant Bacteria
Next articleVTech Announces New KidiZoom Smartwatch DX3, PrintCam and KidiBuzz 3
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.